Villadolid, Ricky M.

HRN: 27-89-76  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2025
CEFTRIAXONE 1G (VIAL)
11/14/2025
11/20/2025
IV
2g IV
Q12
CAP-HR W/ Aspiration Component
Checking Initial Appropriateness 

 Indication:  Culture-directed    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines